Alexander Kutikov MD (@uretericbud) 's Twitter Profile
Alexander Kutikov MD

@uretericbud

Prof & Chair, Dept. of Urology @FoxChaseCancer | Roberta R. Scheller Endowed Chair in Urologic Oncology @FCUroOnc | Fox Chase-Temple Urologic Institute | V/M

ID: 32706948

linkhttp://drkutikov.com calendar_today18-04-2009 01:22:53

8,8K Tweet

11,11K Followers

1,1K Following

Chris Weight (@cjweight) 's Twitter Profile Photo

I can't believe my dear friend Mike Kattan has passed?! You can't summarize a person's life on Twitter but here are a few amazing details if you didn't know ☀️Father of predictive nomograms in Urology ☀️H-index of 158 ☀️Routinely bikes 50-70 miles a day ☀️Understands uncertainty

Alexander Kutikov MD (@uretericbud) 's Twitter Profile Photo

Great trip to the New England Section of the AUA. Fantastic to see mentors, mentees and friends! Special treat to see Frank McGovern who wrote my letter of rec for residency back in the day! Ben Ristau, MD MHA Boris Gershman #neaua24

Great trip to the <a href="/NewEngland_AUA/">New England Section of the AUA</a>. 

Fantastic to see mentors, mentees and friends! 

Special treat to see Frank McGovern who wrote my letter of rec for residency back in the day! <a href="/benristau/">Ben Ristau, MD MHA</a> <a href="/gershmanMD/">Boris Gershman</a>  #neaua24
European Urology (@euplatinum) 's Twitter Profile Photo

Congratulations to our September 2024 Reviewer of the Month, Caroline Moore! Thank you for your continued support to European Urology #ROTM #reviewerofthemonth #UroSoMe #Medtwitter

Congratulations to our September 2024 Reviewer of the Month, <a href="/mrsprostate/">Caroline Moore</a>!  Thank you for your continued support to European Urology  #ROTM #reviewerofthemonth #UroSoMe #Medtwitter
Luca Afferi (@luca_afferi) 's Twitter Profile Photo

Decision science is about taking the right decision for your patient, considering all possible consequences, mixing #QoL+#survival+#costs. Happy to spread info about this scientific method during the Swiss Urology Congress #SGU and to receive nice commentaries from Alexander Kutikov MD

Decision science is about taking the right decision for your patient, considering all possible consequences, mixing #QoL+#survival+#costs. Happy to spread info about this scientific method during the Swiss Urology Congress #SGU and to receive nice commentaries from <a href="/uretericbud/">Alexander Kutikov MD</a>
Alexander Kutikov MD (@uretericbud) 's Twitter Profile Photo

Enjoying the Swiss Urology Congress in Lugano! Congrats to Christian D. Fankhauser and team for deploying an Epic-based follow-up system where patients submit data without scheduled appointments. We’ve done pre-visit surveys—any US experience with post-treatment data collection like this?

Enjoying the Swiss Urology Congress in Lugano! Congrats to <a href="/CDFankhauser/">Christian D. Fankhauser</a> and team for deploying an Epic-based follow-up system where patients submit data without scheduled appointments. We’ve done pre-visit surveys—any US experience with post-treatment data collection like this?
Alexander Kutikov MD (@uretericbud) 's Twitter Profile Photo

Getting back from the Swiss Urology Association meeting in Lugano. Met bright rising Swiss stars like Christian D. Fankhauser and reconnected with old friends. Big thanks to Prof. Dan Eberli for the invite —the event ticked like a Swiss clock. Always refreshing to hear fresh ideas and

Getting back from the Swiss Urology Association meeting in Lugano. Met bright rising Swiss stars like <a href="/CDFankhauser/">Christian D. Fankhauser</a> and reconnected with old friends. Big thanks to Prof. Dan Eberli for the invite —the event ticked like a Swiss clock. Always refreshing to hear fresh ideas and
Tom Powles (@tompowles1) 's Twitter Profile Photo

Nectin-4 is the target for Enfortumab Vedotin and is widely expressed in UC (median 275/300) . EV302 is 1st randomised trial to explore its relationship with response. IHC results show no clear relationship between Nectin-4 and outcome (RR,PFS,OS) or PD-L1 #ESMO2024

Nectin-4 is the target for Enfortumab Vedotin and is widely expressed in UC (median 275/300) . EV302 is 1st randomised trial to explore its relationship with response.  IHC results show no clear relationship between Nectin-4 and outcome (RR,PFS,OS)  or PD-L1  #ESMO2024
Elizabeth Plimack MD (@erplimackmd) 's Twitter Profile Photo

NIAGRA presented #ESMO24 and published today NEJM – huge accomplishment 1000+ patients enrolled. Exciting results! Some thoughts on applying them to practice...

NIAGRA presented #ESMO24 and published today <a href="/NEJM/">NEJM</a> – huge accomplishment 1000+ patients enrolled. Exciting results!
Some thoughts on applying them to practice...
Fox Chase Cancer Center (@foxchasecancer) 's Twitter Profile Photo

Elizabeth Plimack, MD, MS, FASCO, the Deputy Director of Fox Chase Cancer Center (Elizabeth Plimack MD), provides an update on the SWOG S1314 trial for muscle-invasive bladder cancer on GU Oncology Now: bit.ly/4e1zIaw

KidneyCAN (@kidneycan) 's Twitter Profile Photo

We're on the ground today at the Rally for Medical Research in DC! We're joining forces with advocates from the AACR to ask Congress for $51.3 billion for NIH funding. We’re here to make sure #KidneyCancer research is a priority! #AcceleratingCures #RallyMedRes #FundNIH

We're on the ground today at the Rally for Medical Research in DC! We're joining forces with advocates from the AACR to ask Congress for $51.3 billion for NIH funding. We’re here to make sure #KidneyCancer research is a priority!

#AcceleratingCures #RallyMedRes #FundNIH
KidneyCAN (@kidneycan) 's Twitter Profile Photo

Today, KidneyCAN President Bryan Lewis & Board Member Howard McClurd, both #KidneyCancer survivors, are in DC for the Rally for Medical Research. They’re meeting with decision-makers & ensuring the voices of the kidney cancer community are heard. #AcceleratingCures #FundNIH

Today, KidneyCAN President Bryan Lewis &amp; Board Member Howard McClurd, both #KidneyCancer survivors, are in DC for the Rally for Medical Research. They’re meeting with decision-makers &amp; ensuring the voices of the kidney cancer community are heard. 

#AcceleratingCures #FundNIH
Santa Ono (@santajono) 's Twitter Profile Photo

As Chairman of University of Michigan’s Health Board, I am pleased to appoint David C. Miller as CEO of Michigan Medicine and Executive Vice President of Medical Affairs at University of Michigan effective July 1, 2025. It has been an absolute pleasure to work with him in my

As Chairman of University of Michigan’s Health Board,  I am pleased to appoint David C. Miller as CEO of Michigan Medicine and Executive Vice President of Medical Affairs at University of Michigan effective July 1, 2025. It has been an absolute pleasure to work with him in my